Do not toss it in your bag for a gym session and remember it hours later
The glucagon component is thought to enhance thermogenesis the body's heat-generating metabolic processes potentially contributing to fat loss beyond what GLP-1 and GIP agonism alone can achieve
Key topics to discuss include: Your Crohn's disease status: Current disease activity (remission versus active inflammation) Location and extent of disease involvement History of complications (strictures, fistulas, previous surgeries) Recent colonoscopy or imaging findings Current symptom burden and quality of life Current medication regimen: All Crohn's medications (immunosuppressants, biologics, corticosteroids) Other diabetes medications and potential alternatives to Ozempic Any medications for symptom management (antidiarrhoeals, pain relief) Nutritional supplements or vitamin replacements Nutritional and weight considerations: Current nutritional status and any deficiencies Recent weight changes (intentional or unintentional) Dietary restrictions or intolerances Whether weight loss is desirable or potentially harmful in your situation Pregnancy and breastfeeding: Semaglutide should be stopped at least 2 months before a planned pregnancy [1] Effective contraception should be used during treatment Ozempic should not be used during pregnancy Specialist advice should be sought regarding breastfeeding Alternative diabetes management options: Other GLP-1 agonists with potentially different side effect profiles SGLT2 inhibitors, DPP-4 inhibitors, or insulin therapy The relative benefits and risks of each option given your Crohn's disease Monitoring plan: Frequency of follow-up appointments during initiation How to distinguish between Crohn's flares and medication side effects When to contact the medical team Blood tests to monitor diabetes control, renal function and nutritional markers Potential need for faecal calprotectin monitoring to assess inflammation Retinopathy assessment if you have pre-existing diabetic retinopathy Hypoglycaemia risk and monitoring if taking sulfonylureas or insulin Your doctor should provide clear safety netting advice , including specific symptoms that warrant immediate medical review and when to stop Ozempic (e.g., if pancreatitis is suspected)
doi: 10.3389/fphar.2018.00249 69 PetrosinoS.Di MarzoV
The second generation, the dual and triple agonists, was prescribed without regard to genotype because the regulatory infrastructure had not caught up
You can also enroll in a Medicare Supplement Plan N or M, but since there are no guaranteed issue rights for these two plans, you may have to pass medical underwriting before you are accepted for these plans
